Dr Guillaume MOUILLET

ABSTRACTBackgroundSunitinib is a tyrosine kinase inhibitor approved in the first-line metastatic renal cell carcinoma...

Posted by : Dr. Guillaume MOUILLET, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Trials

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...

Posted by : Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Pr. Franck BONNETAIN
Journal name : PlosOne

AbstractNew combinations of antiangiogenic tyrosine kinase inhibitors (TKI) and immune checkpoint inhibitors (ICI) or...

Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

ABSTRACTBACKGROUND: Two main therapies, pazopanib and sunitinib, are used in the first-line setting for metastatic renal...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, , Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET
Journal name : Health and Quality of Life Outcomes

Background: Deficient mismatch repair (dMMR) colon cancer (CC) is reportedly resistant to 5-fluorouracil (5FU) adjuvant...

Posted by : Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET
Journal name : JNCI Journal of the National Cancer Institure

AbstractUntil recently, the first-line treatments used in metastatic renal cell carcinoma were based on first-generation...

Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

AbstractIntroduction - Routine Electronic Monitoring of Health-Related Quality of Life (HRQoL) (REMOQOL) in clinical...

Posted by : Dr. Sophie PAGET-BAILLY, , , Mme. Joëlle FRITZSCH, Mr. Antoine FALCOZ, Dr. Guillaume MOUILLET
Journal name : Quality of Life Research

AbstractBackground Metastatic Squamous cell Penile Carcinoma (mSCPC) is an orphan disease with a virally induced...

Posted by : Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET
Journal name : Bull Cancer

AbstractUntil recently, the first-line treatments used in metastatic renal cell carcinoma were based on first-generation...

Posted by : Dr. Guillaume MOUILLET
Journal name : Bulletin du cancer

AbstractBackground: Surgical resection with adjuvant chemotherapy is the only treatment that can provide long term...

Posted by : Dr. Dewi VERNEREY, Dr. Guillaume MOUILLET, Dr. Angélique VIENOT
Journal name : Front Oncol

Posted by : Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET, Dr. Sophie PAGET-BAILLY

On Friday 17 November, the Quality of Life in Cancer conference, organized by the UMQVC with the support of the Pôle de...

Posted by : Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Mme. Joëlle FRITZSCH